Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 2 (2005), Issue 3 (March)

1. In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.
   J Infect Dis, 191(7): 1196-203. [Abstract] [Full-text]
2. Fulminant cerebral malaria in a Swiss patient.
   Infection, 33(1): 33-5. [Abstract] [Full-text]
3. Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic.
   Clin Diagn Lab Immunol, 12(3): 375-9. [Abstract] [Full-text]
4. Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides.
   Biochem Biophys Res Commun, 329(3): 1053-66. [Abstract] [Full-text]
5. The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria.
   Br J Clin Pharmacol, 59(3): 298-301. [Abstract] [Full-text]
6. Malaria transmission dynamics in central Côte d'Ivoire: the influence of changing patterns of irrigated rice agriculture.
   Med Vet Entomol, 19(1): 27-37. [Abstract] [Full-text]
7. Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum.
   Vaccine, 23(17): 2235-42. [Abstract] [Full-text]
8. The global distribution of clinical episodes of Plasmodium falciparum malaria.
   Nature, 434(7030): 214-7. [Abstract] [Full-text]
9. Direct health costs of occupationally acquired malaria in a military population in Europe.
   Occup Med (Lond), 55(2): 128-30. [Abstract] [Full-text]
10. A method for cross-sector priority setting. Gaps and hypotheses in malaria research: Tanzania.
    Eur J Health Econ, 5(4): 317-23. [Abstract] [Full-text]
11. Avian malaria: clinical and chemical pathology of Plasmodium gallinaceum in the domesticated fowl Gallus gallus.
    Avian Pathol, 34(1): 29-47. [Abstract] [Full-text]
12. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research.
    Annu Rev Immunol, 23: 69-99. [Abstract] [Full-text]
13. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.
    J Infect Dis, 191(8): 1331-41. [Abstract] [Full-text]
14. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children.
    J Infect Dis, 191(8): 1233-8. [Abstract] [Full-text]
15. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children.
    J Neurol Neurosurg Psychiatry, 76(4): 476-81. [Abstract] [Full-text]
16. Peptide mimics as surrogate immunogens of mosquito midgut carbohydrate malaria transmission blocking targets.
    Vaccine, 23(21): 2717-24. [Abstract] [Full-text]
17. Distribution of Plasmodium falciparum genotypes in clinically mild and severe malaria cases in Orissa, India.
    Trans R Soc Trop Med Hyg, 99(5): 389-95. [Abstract] [Full-text]
18. Malaria vectors and urbanization in the equatorial forest region of south Cameroon.
    Trans R Soc Trop Med Hyg, 99(5): 347-54. [Abstract] [Full-text]
19. Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria.
    Trans R Soc Trop Med Hyg, 99(5): 333-40. [Abstract] [Full-text]
20. Evaluating a malaria intervention strategy using knowledge, practices and coverage surveys in rural Bolifamba, southwest Cameroon.
    Trans R Soc Trop Med Hyg, 99(5): 325-32. [Abstract] [Full-text]
21. Caregivers's knowledge, attitude and practice on childhood malaria and treatment in urban and rural communities in Enugu, south-east Nigeria.
    Public Health, 119(5): 409-14. [Abstract] [Full-text]
22. CYP2C8 polymorphism frequencies among malaria patients in Zanzibar.
    Eur J Clin Pharmacol, 61(1): 15-8. [Abstract] [Full-text]
23. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria.
    JAMA, 293(12): 1461-70. [Abstract] [Full-text]
24. Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.
    Infect Immun, 73(4): 2478-85. [Abstract] [Full-text]
25. The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA.
    Infect Immun, 73(4): 2288-97. [Abstract] [Full-text]
26. Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.
    Infect Immun, 73(4): 2281-7. [Abstract] [Full-text]
27. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization.
    Infect Immun, 73(4): 1986-94. [Abstract] [Full-text]
28. Malaria problem in Afghanistan: malaria scanning results of the Turkish medical aid group after the war.
    Transfus Apher Sci, 32(2): 133-7. [Abstract] [Full-text]
29. Transfusion-transmitted malaria: current donor selection guidelines are not sufficient.
    Vox Sang, 88(3): 200-1. [Abstract] [Full-text]
30. Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.
    Antimicrob Agents Chemother, 49(4): 1622-5. [Abstract] [Full-text]
31. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Bull World Health Organ, 83(3): 195-201. [Abstract] [Full-text]
32. Serum ascorbic acid concentration in patients with acute Falciparum malaria infection: possible significance.
    Braz J Infect Dis, 8(5): 378-81. [Abstract] [Full-text]
33. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
    Proc Natl Acad Sci U S A, 102(13): 4836-41. [Abstract] [Full-text]
34. Host cell preference and variable transmission strategies in malaria parasites.
    Proc Biol Sci, 272(1562): 511-7. [Abstract] [Full-text]
35. The financial burden of malaria in Tanzania: implications for future government policy.
    Int J Health Plann Manage, 20(1): 67-84. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.